PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3958646

Methodological concerns in bioethics.

L B McCullough
View original source ↗Export metadata ↓

Abstract

Methodological concerns are moving to the top of the bioethics agenda for the next decade. This paper examines some of those concerns: medical ethics as a subset of bioethics versus medical ethics as a subset of professional ethics; a more in-depth examination of some methodological problems in treating medical ethics as professional ethics; the senses in which bioethics constitutes an inquiry into secular undertakings in a pluralistic society; 'federal ethics', the emergence to prominence of public commissions and study groups; and the institutional impact of bioethics on the relationship between medical schools and the liberal arts core of their sponsoring universities.

Explore related subjects

Advisory CommitteesBeneficenceBioethicsCultural DiversityEthical AnalysisEthical TheoryEthics, MedicalGovernment AgenciesHuman RightsHumansInfant, NewbornMethodsMoral ObligationsPersonal AutonomyPersonhoodPhilosophy, MedicalUnited StatesVirtuesAnalytical ApproachBioethics and Professional EthicsPhilosophical ApproachJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L B McCullough. 1986. Methodological concerns in bioethics.. https://doi.org/10.1093/jmp%2F11.1.17

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2022

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.

Advisory Committees↗